Professional One-Stop Light Therapy Solutions Manufacturer with Over 15 Years of Experience.

Our Blogs

Harnessing Light for

Holistic Wellness

Photodynamic Therapy in California Dermatology: Uses, Procedure, Recovery, and Provider Checklist

2026-06-24

Updated: June 24, 2026 | 11-minute read

Photodynamic therapy, often called PDT, is a clinical treatment that combines a photosensitizing agent with a specific medical light source to target abnormal or precancerous cells. In dermatology, PDT is most commonly used for actinic keratoses, which are rough, sun-damaged precancerous skin lesions that often appear on the face, scalp, arms, and other areas exposed to long-term ultraviolet light.

Unlike standard laser treatments or general light-based skin procedures, PDT is not simply “light therapy.” It requires a photosensitizing agent that makes the target tissue responsive to light. Once activated by the correct wavelength and dose of light, the photosensitizer triggers a photochemical reaction that can damage selected abnormal cells.

In U.S. dermatology, aminolevulinic acid-based PDT has a long regulatory history for treating actinic keratoses. However, the exact approved indication, incubation time, treatment area, light source, and recovery instructions depend on the specific medical protocol used.

This guide explains how PDT is used in California dermatology clinics, which conditions it may be used for, what recovery can look like, and how patients can evaluate whether a provider is qualified to perform the procedure.

What is photodynamic therapy?

Photodynamic therapy is a two-step, light-activated medical treatment. First, a photosensitizing agent is applied to or introduced into the target tissue. Second, the treated area is exposed to a medical light source that activates the photosensitizer.

In dermatology, topical aminolevulinic acid is commonly used. After application, aminolevulinic acid is metabolized into protoporphyrin IX, also known as PpIX, a photoactive compound that can accumulate in abnormal or sun-damaged cells. When exposed to light of an appropriate wavelength and energy, PpIX becomes activated. In the presence of oxygen, this reaction produces reactive oxygen species that damage cellular structures and help destroy the targeted cells.

A dermatologist is applying a photosensitizing agent to a patient's face.

This mechanism makes PDT different from standard laser resurfacing, IPL, or general LED therapy. Those treatments may use light for heating, resurfacing, pigment targeting, or photobiomodulation. PDT, by contrast, depends on the combination of a photosensitizing agent, a controlled light source, oxygen, and an appropriate treatment protocol.

That distinction matters. A red or blue light session used without a photosensitizing agent is not clinical PDT. General light therapy devices operate through different mechanisms and should not be marketed or understood as substitutes for physician-supervised PDT.

Approved uses and off-label uses

The most common approved dermatologic use of aminolevulinic acid-based PDT in the United States is the treatment of actinic keratoses. Actinic keratoses are precancerous lesions caused by cumulative UV exposure, and they are especially common among people with long-term sun exposure, fair skin, outdoor work history, or extensive photodamage.

Approved PDT protocols are specific. They may define the treatment site, lesion thickness, application method, incubation period, and light source. Patients should not assume that every PDT treatment follows the same timing or is approved for the same condition.

Some dermatologists also use PDT outside approved indications. These off-label uses may include acne vulgaris, sebaceous gland hyperplasia, photodamaged skin rejuvenation, and selected superficial nonmelanoma skin cancers in carefully chosen patients. Off-label use does not automatically mean inappropriate use, but it should be explained clearly. Patients should understand whether their treatment is being performed for an approved indication or as an off-label medical decision based on clinical judgment.

PDT is not appropriate for all skin cancers. It should not be presented as a treatment for melanoma or deeply invasive skin cancers. Lesion thickness, diagnosis, location, immune status, and biopsy results all affect whether PDT is suitable.

How the PDT procedure works in a dermatology setting

A dermatology PDT session usually follows a structured sequence, but the details vary by body site, diagnosis, and clinical protocol.

Step-by-step illustration of photodynamic therapy stages in a dermatology setting

1. Skin assessment and treatment planning

Before PDT, the dermatologist evaluates the target lesions and confirms whether PDT is appropriate. For actinic keratoses, the provider may assess lesion thickness, treatment area, skin type, history of skin cancer, immune status, and prior treatments such as cryotherapy, topical medications, or laser procedures.

Suspicious lesions may need biopsy before PDT. A lesion that looks unusually thick, tender, rapidly growing, bleeding, or ulcerated may require diagnostic confirmation rather than immediate field treatment.

2. Skin preparation

The treatment area is usually cleansed. In some cases, the dermatologist may gently remove scale or crust from actinic keratoses to help the medication contact the lesion more evenly. This should be done by trained clinical staff according to the physician's protocol.

3. Photosensitizer application

The photosensitizing agent is applied to the target lesions or treatment field, depending on the indication and protocol. Some protocols focus on individual lesions, while others may involve a broader treatment field when clinically appropriate.

This is one reason patients should ask how the treatment area will be defined. “PDT” is not a single universal procedure. The application area, incubation time, and light source all affect the treatment.

4. Incubation period

The incubation period allows aminolevulinic acid to convert into photoactive porphyrins in the treated tissue. This timing is not arbitrary.

Incubation time can vary depending on the treatment site, lesion type, and clinical protocol. Some protocols use longer incubation periods, while others may use modified or short-contact approaches to improve comfort or scheduling. Because incubation time affects both treatment intensity and side effects, it should be selected by a qualified clinician rather than copied from a generic online guide.

5. Light activation

After incubation, the treated skin is exposed to a specific medical light source. Different wavelengths may be used depending on the protocol and treatment depth needed.

Patients may feel stinging, burning, warmth, or prickling during illumination. This discomfort can vary widely based on treatment site, lesion burden, incubation time, device type, and individual sensitivity.

Medical PDT devices are designed to deliver a controlled light dose. General wellness lights are not validated substitutes for PDT activation and should not be used to activate prescription photosensitizers outside a medical setting.

What conditions can PDT treat?

Actinic keratoses

Actinic keratoses are the clearest and most common dermatologic indication for PDT in U.S. practice. PDT can be useful when a patient has multiple AKs or broader sun-damaged areas that need more than spot treatment.

For example, a patient with scattered AKs across the face or scalp may benefit from a field-directed treatment approach, depending on the clinical protocol used. Compared with treating individual lesions one by one, PDT may help address visible lesions and surrounding areas of photodamage when a field approach is appropriate.

Close-up educational image of actinic keratoses before and after treatment

Superficial nonmelanoma skin cancers

PDT has been studied and used for selected superficial nonmelanoma skin cancers in some clinical contexts. However, the appropriateness of PDT depends heavily on diagnosis, lesion depth, location, immune status, available protocols, and regulatory status.

Patients with suspected skin cancer should not rely on PDT without proper diagnosis. Biopsy and dermatologist evaluation are essential.

Acne vulgaris

PDT has been studied for acne and is sometimes used off-label by dermatologists, especially for patients who have not responded well to standard therapies. The proposed mechanism involves effects on sebaceous glands, inflammation, and acne-associated bacteria.

However, acne PDT results vary. It is not a first-line treatment for most acne patients, and it is not the same as ordinary blue light acne sessions. Patients should discuss expected number of sessions, pain level, downtime, cost, and alternatives such as topical retinoids, benzoyl peroxide, oral antibiotics, hormonal therapy, or isotretinoin.

Photodamage and cosmetic rejuvenation

Some dermatology practices use PDT off-label for photodamaged skin, uneven texture, and visible sun damage. This use is usually positioned as medical-cosmetic rather than purely therapeutic. Patients should be careful with claims such as “reverses aging” or “rebuilds collagen” unless the provider explains the evidence and realistic limitations.

Recovery, side effects, and downtime

PDT recovery is usually visible but manageable. The treated area may look and feel like a sunburn for several days. Redness, swelling, burning, itching, peeling, crusting, scaling, and tenderness can occur. Some patients also experience temporary pigment changes, especially if they have deeper skin tones or if post-treatment light avoidance is not followed carefully.

Patient with mild redness and peeling after PDT treatment

A typical recovery pattern may look like this:

Day 1 to Day 3: Redness, burning sensation, swelling, and tenderness may be most noticeable.
Day 4 to Day 7: Peeling, crusting, and flaking may develop as damaged cells shed.
Week 2 to Week 4: The treated area gradually calms, and the dermatologist can better evaluate lesion clearance.

Recovery depends on treatment intensity, location, skin type, incubation time, and the number of lesions treated. Some patients return to routine activities quickly, while others prefer to schedule treatment before a quieter social or work period because peeling and redness may be visible.

Light avoidance after PDT

Light avoidance is one of the most important aftercare instructions. After a photosensitizing agent is applied, the treated skin becomes photosensitive. Exposure to sunlight or bright indoor light can trigger burning, redness, swelling, and exaggerated skin reactions.

Patients may be instructed to avoid sunlight and bright indoor light for a defined period after treatment. Sunscreens do not fully protect against photosensitivity reactions caused by visible light, so physical protection such as hats, protective clothing, and staying indoors may be necessary.

Patients should follow the exact post-treatment instructions from their dermatologist because aftercare may vary by treatment site and protocol.

When to contact your dermatologist after PDT

Patients should contact their dermatologist promptly if they experience symptoms beyond expected redness and peeling. Warning signs may include:

Severe blistering that extends beyond the treated area
Increasing warmth, swelling, pus, or fever
Pain that worsens rather than improves after the first few days
Eye irritation or vision symptoms after treatment near the eyes
Hives, facial swelling, or signs of allergic reaction
Unusual confusion, fainting, or neurologic symptoms

Most patients are scheduled for follow-up within several weeks so the dermatologist can assess response and decide whether additional treatment is needed. Follow-up is especially important for patients with extensive actinic keratoses, history of skin cancer, or lesions that do not fully clear.

Who is qualified to perform PDT in California?

Clinical PDT should be performed in a medical setting under appropriate physician oversight. Because prescription photosensitizers are involved, PDT is not equivalent to a spa facial or general light-based cosmetic service.

In California, medical spas that offer medical procedures are considered to be providing medical services, not ordinary spa services. Patients should verify that the facility has appropriate physician ownership, supervision, and licensed clinical staff. A dermatologist, Mohs surgeon, or appropriately trained medical professional working under physician supervision is typically the right provider for clinical PDT.

Before booking, patients can ask:

Is the provider a board-certified dermatologist or supervised by one?
What photosensitizing agent will be used?
Is this treatment approved for my condition, or is it off-label?
What type of medical light source will be used?
What incubation time will be used, and why?
How many sessions are usually needed?
What downtime should I expect?
What should I do if I cannot complete the light activation step?
What are the alternatives, such as cryotherapy, topical medications, excision, or laser treatment?

A qualified provider should be comfortable answering these questions clearly.

PDT vs general light therapy: why they are not the same

PDT and general light therapy are often confused because both involve light. However, their mechanisms and safety requirements are different.

PDT uses a photosensitizing agent and a medical light source to create a photochemical reaction that damages targeted cells. It is used in medical dermatology for conditions such as actinic keratoses and, in selected cases, other dermatologic concerns.

General light therapy does not involve a photosensitizing drug. These treatments may be discussed in the context of skin appearance, inflammation, or wellness, but they do not create the same drug-light reaction as PDT.

For this reason, general red light, blue light, or near-infrared light devices should not be described as PDT unless they are being used within a medically supervised PDT protocol with an appropriate photosensitizer and approved medical light source.

Key takeaways

Photodynamic therapy is a medical treatment that combines a photosensitizing agent, oxygen, and a controlled light source to target abnormal or precancerous cells.

In U.S. dermatology, the most established approved use of aminolevulinic acid-based PDT is actinic keratosis treatment. Other uses, such as acne, photorejuvenation, and selected superficial nonmelanoma skin cancers, may be off-label or dependent on the specific clinical context.

Patients should not assume that all PDT protocols are the same. Incubation time, application area, light source, treatment depth, and aftercare instructions can vary.

For California patients, the safest starting point is a board-certified dermatologist or a properly supervised medical dermatology practice that can explain the diagnosis, protocol, risks, downtime, and alternatives.

Frequently Asked Questions

Is photodynamic therapy approved?

Yes, but approval depends on the specific indication and protocol. In U.S. dermatology, aminolevulinic acid-based PDT is most commonly associated with approved treatment of actinic keratoses. Uses such as acne or cosmetic rejuvenation are generally off-label.

What type of doctor performs PDT?

Board-certified dermatologists perform or supervise most PDT procedures for skin conditions. Mohs surgeons, oncologic dermatologists, and other trained medical professionals may also use PDT in selected cases. In some clinics, licensed clinical staff may assist with parts of the procedure under physician supervision.

What is the PDT procedure in dermatology?

A standard dermatology PDT session includes skin assessment, preparation of the treatment area, application of a topical photosensitizing agent, an incubation period, and activation with a medical light source. The exact timing and light source depend on the treatment site and protocol.

Is PDT painful?

PDT can cause burning, stinging, warmth, or prickling during light activation. Some patients describe the sensation as mild, while others find it intense. Pain level depends on incubation time, treatment area, lesion burden, light source, and individual sensitivity.

How long is recovery after PDT?

Visible redness, swelling, peeling, and crusting often last several days to one or two weeks. Some patients look noticeably red or flaky during the first week. The final treatment response is usually assessed after the skin calms, often within several weeks.

Can PDT treat acne?

PDT is sometimes used off-label for acne, especially in patients who have not responded to standard acne treatments. However, it is not usually considered a first-line acne treatment. Results vary, and patients should discuss alternatives, risks, cost, and expected number of sessions.

Can I use general light therapy instead of PDT?

No. General light therapy used without a photosensitizing agent is not PDT. PDT requires a medically supervised protocol that combines a photosensitizer with a controlled medical light source.